incyte (INCY) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

incyte (INCY)

127.91

-0.92 (0.71%)

as of Sep 3, 2026, 7:40:01 pm Market Open.

3 watching

Investor Insights

Sep 2, 2026, 12:00 am

This summary was created by AI, based on 1 opinions in the last 12 months.

Incyte Corporation (INCY-Q) is showing promising potential with a projected earnings growth of 19% by 2026, which has caught the attention of investors. Currently, the stock trades at a remarkable low valuation of under 12 times its projected 2026 earnings, suggesting an attractive entry point for prospective buyers. The company has a robust pipeline of drugs, indicating a strong commitment to innovation and growth within the pharmaceutical sector. Analysts appear optimistic about its future performance, highlighting the potential for significant returns if the company successfully capitalizes on its ongoing projects. Overall, Incyte represents an intriguing opportunity in the market, especially for those looking for growth at a reasonable price.

Consensus

Positive

Valuation

Undervalued

Similar

Regeneron,REGN

BUY

Projected 19% earnings growth in 2026, yet trades at under 12x PE 2026. Has a robust drug pipeline.

Wealthica Track your Stocks in your Watch List

DON'T BUY

The momentum has broken badly and has a high PE. But he entered this on a rebound that has momentum. Despite an upgrade today, he doesn't see a green light ahead.

Showing 1 to 2 of 2 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

Dan Rohinton

iA Global Asset Management

Bruce Campbell (2)

Stone Castle Investment Management Inc.

incyte (INCY) Frequently Asked Questions

What is incyte stock symbol?

incyte is a American stock, trading under the symbol INCY (previously INCY-Q on Stockchase) on the NASDAQ (INCY). It is usually referred to as NASDAQ:INCY or INCY

Is incyte a buy or a sell?

In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on INCY (previously INCY-Q on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for incyte.

Is incyte a good investment or a top pick?

incyte was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for incyte.

Why is incyte stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for incyte.

Is incyte worth watching?

incyte is covered by Stockchase experts and is worth watching.

What is incyte stock price?

On 2026-09-03, incyte (INCY) stock closed at a price of $127.91.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].